Headache induced by the use of combined oral contraceptives

Neurological Sciences

Volumn 30, Issue SUPPL. 1, 2009, Pages

  Allais, Gianni ^a   Castagnoli Gabellari, Ilaria ^a   Airola, Gisella ^a   Borgogno, Paola ^a   Schiapparelli, Paola ^a   Benedetto, Chiara ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Clinical features; Combined oral contraceptives; Estrogen withdrawal headache; Exogenous hormone induced headache; Migraine

Indexed keywords

DESOGESTREL PLUS ETHINYLESTRADIOL; GESTAGEN; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

ARTICLE; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DRUG WITHDRAWAL; HUMAN; MENSTRUAL MIGRAINE; MENSTRUATION; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA;

ADULT; CONTRACEPTIVES, ORAL, COMBINED; ESTROGENS; FEMALE; HEADACHE; HORMONES; HUMANS; MENSTRUAL CYCLE; MIDDLE AGED; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS; YOUNG ADULT;

EID: 65549132837     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-009-0051-9     Document Type: Article

References (17)

1. Loder EW, Buse DC, Golub JR (2005) Headache as a side effect of combination estrogen-progestin oral contraceptives: A systematic review. Am J Obstet Gynecol 193:636-649
2. Headache Classification Subcommittee of the International Headache Society (IHS) (2004) The International Classification of Headache Disorders (2nd edition). Cephalalgia 24(Suppl 1):1-151
3. Mueller L (2000) Predictability of exogenous hormone effect in subgroups of migraineurs. Headache 40:189-193
4. Granella F, Sances G, Pucci E, Nappi RE, Ghiotto N, Nappi G (2000) Migraine with aura and reproductive life events: A case control study. Cephalalgia 20(8):701-707
5. MacGregor EA, Igarashi H, Wilkinson M (1997) Headaches and hormones: subjective versus objective assessment. Headache Q 8:126-136
6. Cupini LM, Matteis M, Troisi E, Calabresi P, Bernardi G, Silvestrini M (1995) Sex-hormone-related events in migrainous females. A clinical comparative study between migraine with aura and migraine without aura. Cephalalgia 15:140-144
7. Granella F, Sances G, Zanferrari C, Costa A, Martignoni GC (1993) Migraine without aura and reproductive life events: A clinical epidemiological study in 1300 women. Headache 33:385-389
8. Massiou H, MacGregor EA (2000) Evolution and treatment of migraine with oral contraceptives. Cephalalgia 20:170-174
9. Fotherby K (1992) Clinical experience and pharmacological effects of an oral contraceptive containing 20 micrograms oestrogen. Contraception 46:477-488
10. Gerais AS, Rushwan H (1985) A crossover pill study among Sudanese women. Int J Gynaecol Obstet 23:229-233
11. Edelman DA, Kothenbeutel R, Levinski MJ, Kelly SE (1983) Comparative trials of low-dose combined oral contraceptives. J Reprod Med 28:195-200
12. Sulak PJ, Scow RD, Preece C, Riggs MW, Kuehl TJ (2000) Hormone withdrawal symptoms in oral contraceptive users. Obstet Gynecol 95:261-266
13. Aegidius K, Zwart JA, Hagen K, Schei B, Stovner LJ (2006) Oral contraceptives and increased headache prevalence. The Head-HUNT study. Neurology 66:349-353
14. Guillebaud J (1983) The 150/30 formulation. Experience in the United Kingdom. J Reprod Med 28(1 Suppl):66-70
15. Fotherby K (1995) Twelve years of clinical experience with an oral contraceptive containing 30 μg ethinyloestradiol and 150 μg desogestrel. Contraception 51:3-12
16. Ryan RE (1978) A controlled study of the effect of oral contraceptives on migraine. Headache 17:250-252
17. Allais G, Bussone G, Airola G, Borgogno P, Castagnoli Gabellari I, De Lorenzo C et al (2008) Oral contraceptive-induced menstrual migraine. Clinical aspects and response to frovatriptan. Neurol Sci 29(Suppl 1):S186-S190